See the DrugPatentWatch profile for Norditropin
Norditropin is a brand name for somatropin, a synthetic human growth hormone used to treat growth failure in children and adults [1]. It is administered via injection [2].
What is Norditropin used for?
Norditropin is prescribed for various conditions characterized by insufficient growth hormone production. In children, it treats growth failure associated with conditions like idiopathic short stature, Prader-Willi syndrome, Turner syndrome, and intrauterine growth restriction [3]. For adults, it is used to treat severe adult growth hormone deficiency [3].
How is Norditropin administered and what are the dosage forms?
Norditropin is administered subcutaneously, meaning it is injected under the skin [2]. It is available in several formulations, including Norditropin SimpleXx and Norditropin FlexPro, which are pre-filled pens designed for easier self-administration [4]. The dosage is determined by a healthcare provider based on the individual's condition, age, weight, and response to treatment [3].
What are the potential side effects of Norditropin?
Common side effects of Norditropin can include injection site reactions (pain, redness, itching), muscle pain, joint pain, and swelling in the arms or legs [5]. Less common but more serious side effects can include increased blood sugar levels, carpal tunnel syndrome, and allergic reactions [5]. It is important for patients to discuss any concerns about side effects with their doctor.
How long does it take to see results from Norditropin?
The time it takes to see results can vary depending on the individual and the condition being treated. For children experiencing growth failure, improvements in growth rate are typically observed within the first few months of consistent treatment [3]. For adults, improvements may relate to changes in body composition and well-being, which can also vary in onset [3].
When does Norditropin's patent protection expire?
Drug patent information can be complex and subject to change. For detailed and up-to-date information on Norditropin's patent status and potential exclusivity periods, DrugPatentWatch.com is a valuable resource [6]. Patent expiry dates determine when generic or biosimilar versions of a drug may become available.
Who manufactures Norditropin?
Norditropin is manufactured by Novo Nordisk [1].
Are there alternatives to Norditropin?
Yes, other brands of synthetic human growth hormone are available, such as Genotropin, Humatrope, and Omnitrope [7]. These are also somatropin products and are used for similar indications. The choice of treatment often depends on factors like physician preference, insurance coverage, and patient response [7].
Sources:
[1] https://www.norditropin.com/
[2] https://www.webmd.com/drugs/2/drug-77776/norditropin-injection/details
[3] https://www.mayoclinic.org/drugs-supplements/somatropin-injection-route/proper-use/dr-20068678
[4] https://www.goodrx.com/norditropin
[5] https://www.drugs.com/sfx/norditropin-side-effects.html
[6] https://drugpatentwatch.com/
[7] https://www.health.harvard.edu/blog/the-grown-ups-guide-to-human-growth-hormone-2017031411361